Clinical Trials on Long-term Survivors in Belgium

Total 2182 results

University Hospital, Ghent
VZW kinderkankerfonds, Belgium

Recruiting

Multidisciplinary Rehabilitation of Children and Adolescents After Acute Cancer Treatment

Rehabilitation | Exercise Therapy | Cancer Survivors

Belgium
Universitaire Ziekenhuizen KU Leuven
Fund for Scientific Research, Flanders, Belgium

Completed

Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan (PainsCan)

Cancer Pain | Cancer Survivors

Belgium
Vrije Universiteit Brussel
University of Calgary; University Hospital, Ghent; Universitair Ziekenhuis Brussel and other collaborators

Not yet recruiting

Co-creation of Pain Science Education for Children Living Beyond Cancer (PANACEA)

Children Living Beyond Cancer (i.e. Child Cancer Survivor)

Belgium
Universitair Ziekenhuis Brussel
Brugmann University Hospital

Recruiting

Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Advanced Cancer Survivors Treated With Immunotherapy and the Efficacy of Integrative Neurocognitive Remediation Therapy (CognIT)

Quality of Life | Cognitive Dysfunction | Psychological Distress | Immunotherapy | Cognitive Behavioral Therapy | Cancer Survivors | Cognitive Remediation | Neuropsychology | Psycho-Oncology

Belgium
Biotronik AG

Completed

PROGRESS-AMS 1.0 Clinical Long Term Follow-Up

Long Term Safety of the AMS 1.0

Switzerland, Germany, Australia, Belgium, Netherlands
Universitair Ziekenhuis Brussel
Vrije Universiteit Brussel; Fund for Scientific Research, Flanders, Belgium

Active, not recruiting

The Effect of Pain Neuroscience Education and Behavioural Graded Activity on Chronic Pain in Breast Cancer Survivors (BCS-PAIN)

Breast Neoplasms | Chronic Pain | Survivors

Belgium
University Hospital, Gasthuisberg

Completed

Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors

Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators

Belgium
Davy Vancampfort

Recruiting

Intervention Study of an Individualized Exergame Training for People With Major Neurocognitive Disorder

Nursing Home | Major Neurocognitive Disorder | Exergame | Long-term Care Facility

Belgium
Davy Vancampfort

Unknown

Exergaming in People With Major Neurocognitive Disorder

Physical Activity | Cognitive Impairment | Major Neurocognitive Disorder | Long-term Care Facility | Randomised Controlled Trial

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Endothelial Dysfunction in Covid-19 (ENDOCOVID)

Covid19 | Hypoxemic Respiratory Failure

Belgium
Asylia Diagnostics BV

Recruiting

Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors

Melanoma | Lung Cancer

Belgium
Jules Bordet Institute

Recruiting

Multidisciplinary Approach to Fatigue

Breast Cancer | Germ Cell Tumor

Belgium
University Hospital, Ghent

Completed

Optimizing Ovarian Stimulation for IVF and ICSI

Efficiency in Terms of Mature Oocyte Yield

Belgium
Brugmann University Hospital

Recruiting

Long-term Effects of SARS-CoV-2 on the Central Nervous System and One-year Follow-up of "Long COVID-19" Patients

Long Covid19

Belgium
University Hospital, Ghent

Completed

Short-term Memory Assessment in Patients With Poststroke Aphasia

Aphasia, Acquired | Short-Term Memory Impairment

Belgium
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; University Hospital, Antwerp; NETwerk, Belgium

Completed

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

Neuroendocrine Tumors

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

Neuroendocrine Tumors

Belgium
Universitair Ziekenhuis Brussel
Vrije Universiteit Brussel

Completed

Nutrition and LOComotoric Rehabilitation in Long COVID-19 (UNLOCK)

COVID-19

Belgium
Jules Bordet Institute

Completed

177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs (LUMEN)

Gastroenteropancreatic Neuroendocrine Tumors

Belgium
Universitair Ziekenhuis Brussel

Active, not recruiting

Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC) (myDCTV)

Melanoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Terminated

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Neuroendocrine Tumors | Neural Crest Tumor

Belgium
Cliniques universitaires Saint-Luc- Université...
Immutep S.A.S.

Terminated

Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

Melanoma

Belgium
Cliniques universitaires Saint-Luc- Université...
Institut Pasteur

Unknown

Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients (THERAVAC)

Melanoma

Belgium
University Hospital, Ghent
Jessa Hospital; University Hospital, Antwerp; AZ Sint-Jan AV; AZ Delta; General Hospital... and other collaborators

Terminated

BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs (BLOOD)

Melanoma | Cancer

Belgium
Cliniques universitaires Saint-Luc- Université...

Terminated

Peptide Vaccinations Plus GM-CT-01 in Melanoma

Metastatic Melanoma

Belgium
Universitair Ziekenhuis Brussel

Completed

Dabrafenib and Trametinib for BRAF-inhibitor Pretreated Patients

Malignant Melanoma

Belgium
Universiteit Antwerpen
UZA Foundation

Active, not recruiting

Neurobiological Underpinnings of Neuropsychological Consequences in Long COVID (Cov-N-Psy)

Long COVID

Belgium
Ludwig Institute for Cancer Research

Terminated

Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma

Malignant Melanoma

Belgium
Ludwig Institute for Cancer Research

Terminated

Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

Malignant Melanoma

Belgium
Cliniques universitaires Saint-Luc- Université...

Terminated

Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma

Metastatic Melanoma

Belgium
Nouscom SRL

Active, not recruiting

Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma

Melanoma (Skin) | Non-Small-Cell Lung Carcinoma

Belgium, Spain, United Kingdom
KU Leuven

Unknown

Innovation in Endobronchial Sampling

Diffuse Interstitial Lung Disease

Belgium
Jules Bordet Institute

Recruiting

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Melanoma | Renal Cell Carcinoma | Breast Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Non Small Cell Lung Cancer | Mesothelioma, Malignant | Bladder Cancer | Gastrointestinal Cancer | Merkel Cell Carcinoma | Non-melanoma Skin Cancer | MSI-H Colorectal Cancer

Belgium
KU Leuven

Not yet recruiting

Diagnostic Value of Transbronchial Lung Cryobiopsy

Interstitial Lung Disease

Belgium
Novartis Pharmaceuticals
University of Pennsylvania

Recruiting

CAR-T Long Term Follow Up (LTFU) Study (PAVO)

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program

United States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
Jules Bordet Institute

Withdrawn

Randomized Phase III of PRRT Versus Interferon (CASTOR)

Gastro-intestinal Neuroendocrine Tumors

Belgium
Bart Neyns

Completed

A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Melanoma

Belgium
University Hospital, Ghent

Completed

Resistance Training in Patients With Chronic Obstructive Lung Disease (COPD): Whole Body Vibration Versus Conventional Resistance Training (REWORK)

COPD

Belgium
Universitair Ziekenhuis Brussel
University Hospital, Ghent

Recruiting

Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma (COMBI-R2)

Melanoma

Belgium
University Hospital, Ghent
University Ghent; Kom Op Tegen Kanker

Active, not recruiting

MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer (MIDRIXNEO)

Non-small Cell Lung Cancer

Belgium
Universitair Ziekenhuis Brussel

Active, not recruiting

Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma (GlitIpNi)

Glioblastoma

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Recruiting

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

NSCLC | Lung Diseases, Interstitial | Immunotherapy

Belgium
KU Leuven

Completed

Enhancing Physical Activity in Patients With Interstitial Lung Disease

Interstitial Lung Disease | Interstitial Pulmonary Fibrosis

Belgium
Centre Hospitalier Universitaire de Liege

Active, not recruiting

Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study) (TEN)

Non-small Cell Lung Cancer

Belgium
University Hospital, Ghent
University Ghent; Kom Op Tegen Kanker

Active, not recruiting

MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer (MIDRIX4-LUNG)

Non-small Cell Lung Cancer Metastatic

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Endobronchial Valves in Persistent Air Leak

Malignant Neoplasm of Lung

Belgium
Jules Bordet Institute

Recruiting

Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors (LIFE)

Non Small Cell Lung Cancer

Belgium
University Hospital, Ghent
Nationaal Kankerplan

Terminated

Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers (PEARL-2)

Inoperable Early Stage Non-small Cell Lung Cancer

Belgium
European Organisation for Research and Treatment...

Terminated

Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery

Lung Cancer

Belgium
Vrije Universiteit Brussel
Kom Op Tegen Kanker

Unknown

Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLC

Lung Cancer, Non-small Cell

Belgium

Clinical Trials on Long-term Survivors in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations